scholarly article | Q13442814 |
P2093 | author name string | Arbeitskreis Blut, Untergruppe «Bewertung Blutassoziierter Krankheitserreger» | |
P2860 | cites work | Antigenic drift and variability of influenza viruses. | Q50711179 |
Comparison of two rapid influenza A/B test kits with reference methods showing high specificity and sensitivity for influenza A infection. | Q51242472 | ||
Rapid detection of influenza A neuraminidase subtypes by cDNA amplification coupled to a simple DNA enzyme immunoassay. | Q53019815 | ||
Proved viraemia in asian influenza (Hong Kong variant) during incubation period | Q57116672 | ||
Enzyme-linked immunosorbent assay of core antigens for clinical diagnosis of influenza | Q57219203 | ||
Detection of influenza A and B in respiratory secretions with the polymerase chain reaction | Q67980670 | ||
Viraemia in influenza. A report of two cases | Q70639695 | ||
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child | Q79364184 | ||
Detection of influenza A in clinical specimens and cell culture fluid by a commercial EIA | Q81064546 | ||
Stability of infectious influenza A viruses at low pH and at elevated temperature | Q93641371 | ||
Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls | Q24556678 | ||
Influenza associated excess mortality in Germany, 1985-2001. | Q24814492 | ||
Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma | Q28235537 | ||
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia | Q28262914 | ||
Avian influenza A (H5N1) infection in humans | Q28274603 | ||
Mortality associated with influenza and respiratory syncytial virus in the United States | Q29615578 | ||
Seasonal and pandemic influenza preparedness: science and countermeasures | Q30230207 | ||
The importance of animal influenza for human disease. | Q30331152 | ||
Avian flu: isolation of drug-resistant H5N1 virus. | Q30351638 | ||
Antiviral resistance in influenza viruses--implications for management and pandemic response. | Q30353085 | ||
Antiviral management of seasonal and pandemic influenza. | Q30358735 | ||
H5N1 influenza virus and the safety of plasma products. | Q30360023 | ||
Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics | Q30396327 | ||
Influenza: an emerging disease | Q30431321 | ||
Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. | Q33243576 | ||
A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. | Q33957993 | ||
Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples | Q33966513 | ||
Typing and subtyping of influenza viruses in clinical samples by PCR. | Q36521781 | ||
Use of PCR-enzyme immunoassay for identification of influenza A virus matrix RNA in clinical samples negative for cultivable virus | Q37072968 | ||
Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. | Q39848699 | ||
Emergence of influenza A H1N2 reassortant viruses in the human population during 2001. | Q40637055 | ||
A comparison of direct immunofluorescence, shell vial culture, and conventional cell culture for the rapid detection of influenza A and B. | Q41692868 | ||
The first confirmed human case of avian influenza A (H5N1) in Mainland China | Q43177073 | ||
Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. | Q43207722 | ||
Viremia in Asian influenza | Q43208515 | ||
Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism | Q43209190 | ||
Influenza pneumonia: a descriptive study | Q43635228 | ||
Influenza A outbreak among adolescents in a ski hostel | Q44601751 | ||
Molecular characterization of human influenza viruses--a look back on the last 10 years | Q44628916 | ||
Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology | Q45014650 | ||
Type-specific identification of influenza viruses A, B and C by the polymerase chain reaction | Q45128837 | ||
Fatal influenza A virus infection in a child vaccinated against influenza | Q45728931 | ||
Detection of influenza B virus in throat swabs using the polymerase chain reaction | Q45874297 | ||
On the origin of the human influenza virus subtypes H2N2 and H3N2 | Q45889841 | ||
Detection and identification of human influenza viruses by the polymerase chain reaction | Q48223171 | ||
Complications of influenza and benefits of vaccination. | Q50651491 | ||
P433 | issue | 1 | |
P304 | page(s) | 32-39 | |
P577 | publication date | 2009-01-01 | |
P1433 | published in | Transfusion Medicine and Hemotherapy | Q15758504 |
P1476 | title | Influenza Virus. | |
P478 | volume | 36 |
Q57027404 | C-reactive protein as a biomarker of severe H1N1 influenza |
Q95604073 | Dwindling blood reserves: An ominous downside of COVID-19 pandemic |
Q92619565 | Greater Efficacy of Black Ginseng (CJ EnerG) over Red Ginseng against Lethal Influenza A Virus Infection |
Q24193398 | Interventions for preventing influenza: an overview of Cochrane systematic reviews |
Q24235679 | Interventions for preventing influenza: an overview of Cochrane systematic reviews |
Q24193395 | Interventions for treating influenza: an overview of Cochrane systematic reviews |
Q24234345 | Interventions for treating influenza: an overview of Cochrane systematic reviews |
Q94457634 | QUATgo: Protein quaternary structural attributes predicted by two-stage machine learning approaches with heterogeneous feature encoding |